BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29924239)

  • 1. Tuberous sclerosis complex: review based on new diagnostic criteria.
    Portocarrero LKL; Quental KN; Samorano LP; Oliveira ZNP; Rivitti-Machado MCDM
    An Bras Dermatol; 2018 Jun; 93(3):323-331. PubMed ID: 29924239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberous sclerosis complex: multisystem hamartomas.
    Naderi N; Timofte I; McCurdy MT; Reed RM
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25618887
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-level mosaicism in tuberous sclerosis complex in four unrelated patients: Comparison of clinical characteristics and diagnostic pathways.
    Manzanilla-Romero HH; Weis D; Schnaiter S; Rudnik-Schöneborn S
    Am J Med Genet A; 2021 Dec; 185(12):3851-3858. PubMed ID: 34328706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, pathological, and molecular correlation of folliculocystic and collagen hamartoma: A new potential diagnostic criterion for tuberous sclerosis complex?
    Apam-Garduño D; Cazarín-Barrientos J; Hernández-Martínez NL; Reyna-Fabián ME; Magaña M; Alcántara-Ortigoza MA; González-Del Angel A; Rivera-Vega MR
    J Cutan Pathol; 2023 Jun; 50(6):481-486. PubMed ID: 36229934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging treatments in the management of tuberous sclerosis complex.
    Kohrman MH
    Pediatr Neurol; 2012 May; 46(5):267-75. PubMed ID: 22520346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From gene to disease; TSC1 and TSC2 genes and tuberous sclerosis complex].
    Verhoef S; Lindhout D; Halley DJ; van den Ouweland AM
    Ned Tijdschr Geneeskd; 2001 Oct; 145(40):1928-30. PubMed ID: 11675974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuberous sclerosis].
    Metsähonkala L; Valanne L; Anttonen AK
    Duodecim; 2013; 129(17):1779-87. PubMed ID: 24159711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
    Sampson JR
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.
    Niida Y; Stemmer-Rachamimov AO; Logrip M; Tapon D; Perez R; Kwiatkowski DJ; Sims K; MacCollin M; Louis DN; Ramesh V
    Am J Hum Genet; 2001 Sep; 69(3):493-503. PubMed ID: 11468687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Genetic Analysis Results of TSC1/TSC2 Genes in Patients with Clinical Suspicion of Tuberous Sclerosis Complex and Definition of 3 Novel Variants.
    Demir S; Yalçıntepe S; Atlı E; Yalçın Y; İkbal Atlı E; Eker D; Karal Y; Gürkan H
    Balkan Med J; 2021 Nov; 38(6):341-347. PubMed ID: 34860161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberous Sclerosis Complex: A Review.
    Randle SC
    Pediatr Ann; 2017 Apr; 46(4):e166-e171. PubMed ID: 28414398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex.
    Jóźwiak S; Kotulska K; Kasprzyk-Obara J; Domańska-Pakieła D; Tomyn-Drabik M; Roberts P; Kwiatkowski D
    Pediatrics; 2006 Oct; 118(4):e1146-51. PubMed ID: 16940165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Novel TSC2 c.170G>A Missense Variant: A Case Report and Elaboration on the Yield of Targeted Options against Tuberous Sclerosis Complex Manifestations.
    Papageorgiou G; Skouteris N; Valavanis C; Stanc GM; Souka E; Charalampakis N
    Rev Recent Clin Trials; 2023; 18(4):304-312. PubMed ID: 37877150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberous sclerosis complex: Recent advances in manifestations and therapy.
    Wataya-Kaneda M; Uemura M; Fujita K; Hirata H; Osuga K; Kagitani-Shimono K; Nonomura N;
    Int J Urol; 2017 Sep; 24(9):681-691. PubMed ID: 28667702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of tuberous sclerosis in children].
    Riquet A; Cuisset JM; Cuvellier JC; Joriot S; Petit F; Vallée L
    Arch Pediatr; 2010 Sep; 17(9):1338-45. PubMed ID: 20709508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic update in tuberous sclerosis complex: the role of mTOR pathway inhibitors].
    Ruiz-Falcó Rojas ML
    Rev Neurol; 2012 May; 54 Suppl 3():S19-24. PubMed ID: 22605628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of TSC1 and TSC2 genes and phenotypic correlations in Brazilian families with tuberous sclerosis.
    Rosset C; Vairo F; Bandeira IC; Correia RL; de Goes FV; da Silva RTB; Bueno LSM; de Miranda Gomes MCS; Galvão HCR; Neri JICF; Achatz MI; Netto CBO; Ashton-Prolla P
    PLoS One; 2017; 12(10):e0185713. PubMed ID: 28968464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation screening of TSC1 and TSC2 genes in Chinese Han children with tuberous sclerosis complex.
    Mi CR; Wang H; Jiang H; Sun RP; Wang GX
    Genet Mol Res; 2014 Mar; 13(1):2102-6. PubMed ID: 24737435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberous Sclerosis Complex: Genetic counselling and perinatal follow-up.
    Touraine R; Hauet Q; Harzallah I; Baruteau AE
    Arch Pediatr; 2022 Dec; 29(5S):5S3-5S7. PubMed ID: 36585068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberous sclerosis complex: a review.
    Leung AK; Robson WL
    J Pediatr Health Care; 2007; 21(2):108-14. PubMed ID: 17321910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.